Skip to main content

Table 1 Participants excluded because of poor mutation-screening performance by study centera

From: Rare, evolutionarily unlikely missense substitutions in CHEK2contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study

Center

Patients, n(%)

Controls, n(%)

Breast CFR Australia

5 (0.8%)

11 (2.1%)

Breast CFR Canada

1 (0.3%)

2 (0.4%)

Breast CFR Northern California

4 (1.0%)

1 (0.7%)

Total

10 (0.8%)

14 (1.2%)

  1. a All 10 excluded patients were <42 years old, and all 14 excluded controls were <45 years old; percentage data are the percentages of the total number of patient or control DNA provided by the indicated Breast CFR center; Breast CFR, Breast Cancer Family Registry.